CRCM
CDLX icon

Crystal Rock Capital Management’s Cardlytics CDLX Stock Holding History

Crystal Rock Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,825
Closed -$988K – 32
2020
Q1 		$988K Buy
+2,825
New +$2M 0.87% 27

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

Crystal Rock Capital Management's CDLX Position: Q2 2020 in Review

Crystal Rock Capital Management sold out of Cardlytics (CDLX) in Q2 2020, closing a stake of 2,825 shares — an estimated $988K sold.

Crystal Rock Capital Management first reported a position in CDLX in Q1 2020 and held it in 1 quarter. The position peaked at $988K in Q1 2020. 164 funds tracked by Wall St. Rank hold CDLX as of Q2 2020.

  • Crystal Rock Capital Management reported no remaining Cardlytics position as of Q2 2020 after selling out during the quarter.
  • Crystal Rock Capital Management sold 2,825 Cardlytics shares in Q2 2020, an estimated $988K.
  • Crystal Rock Capital Management first reported a position in Cardlytics in Q1 2020 and held it in 1 quarter.
  • Crystal Rock Capital Management's Cardlytics position peaked at $988K in Q1 2020.
  • 164 funds tracked by Wall St. Rank held Cardlytics as of Q2 2020.

Based on Crystal Rock Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.